Helmholtz Diabetes Center

Institute for Diabetes and Endocrinology

Our entire lives are controlled by hormones, every minute of every day! At the Institute for Diabetes and Endocrinology (IDE) we are applying cutting-edge genomic technologies to uncover novel mechanisms and drug targets regulating metabolic and inflammatory gene networks.

Follow us on X

Institute Director

Our entire lives are controlled by hormones, every minute of every day! At the Institute for Diabetes and Endocrinology (IDE) we are applying cutting-edge genomic technologies to uncover novel mechanisms and drug targets regulating metabolic and inflammatory gene networks.

Follow us on X

Institute Director

DNA strands on Scientific background. 3d illusation

About our Research

Hormones like Glucocorticoids are powerful physiological regulators and important drugs (for example cortisol, cortisone, dexamethasone, prednisone). They bind to and activate the Glucocorticoid Receptor, which is a member of the nuclear hormone receptor superfamily of transcription factors. Here at IDE, we are studying Glucocorticoid responses as an entry point for the discovery of novel molecular mechanisms underlying the pathology of metabolic and inflammatory disorders, and for the identification of innovative therapeutic approaches. Our scientists are combining preclinical models and molecular genetic tools with omics and bioinformatics approaches to understand how stress hormones or immunomodulatory drugs control gene networks. Current areas of interest include circadian rhythms, nutritional programming, hepatic metabolism and aging.

Research Areas

Circadian Health concept background

Circadian Rhythms

IDE scientists are curious to find out how 24 hour rhythms of light/dark, feeding and fasting, sleep-wake and activity or rest shape our chromatin landscapes to control metabolism and hormone responses.

cortisol molecular structure 3d, flat model, steroid hormone, structural chemical formula view from a microscope

Innate Immune Responses

Glucocorticoids are potent, life-saving anti-inflammatory agents, but their clinical use is limited by severe side effects. At IDE, we are taking a multi-omics approach to identify novel immunomodulatory networks and key regulators.

Human liver anatomy with DNA structure, 3d render. 3d render

Fatty Liver Disease

Currently, therapeutic options for the treatment of non-alcoholic fatty liver disease, hepatic fibrosis and liver cancer are very limited. Researchers at IDE are using preclinical disease models to find out which nuclear hormone receptors or co-regulators may be amenable for drug targeting, and how nutrition affects the pathogenesis of hepatic fibrosis and steatosis.

intermittent fasting diet concept Generative AI

Aging

Caloric restriction is well known to extend both life and health span in a wide range of organisms. IDE scientists are curious to find out which hormonal signals are mediating these beneficial effects on longevity, and how to use this knowledge to liver longer, better.

Staff

Henriette Uhlenhaut Porträt freigestellt
Prof. Dr. Nina Henriette Uhlenhaut

Director of the Institute for Diabetes and Endocriology, IDE

View profile
Dr. Fabiana Quagliarini

Senior Scientist

Dr. Sybille Regn

Scientific Coordination

Judith Brehme

HELENA Graduate School Office, Scientific Talent and Career Development

freigestelltes Porträtbild für Kontakte auf der Website
Lina Fadel

Postdoc

Dr. Celine Jouffe

Postdoc

freigestelltes Porträtbild für Kontakte auf der Website
Vlera Fonda

PhD

Priya Singh

PhD

freigestelltes Porträtbild für Kontakte auf der Website
Teresa Horn

Lab Manager

Kristina Beresowski

Technical Assistant

Betty Haderlein

Technical Assistant

Highlight Publications

2025 Nature Communications

Makris K, Fonda V, Ramadhani FF, Fadel L, Davezac M, Payet B, Deligiannis IK, Zhang L, Horn T, Heimerl L, Jouffe C, Heddes M, Martinez-Jimenez CP, Quagliarini F, Uhlenhaut NH

Hepatic metabolic reprogramming in male mice during short-term caloric restriction involves enhanced glucocorticoid rhythms
2025 Cell

Trendel J, Trendel S, Sha S, Greulich F, Goll S, Wudy SI, Kleigrewe K, Kubicek S, Uhlenhaut NH, Kuster B

The human proteome with direct physical access to DNA
2023 Computational and Structural Biotechnology Journal

Höllbacher B, Strickland B, Greulich F, Uhlenhaut NH, Heinig M

Machine learning reveals STAT motifs as predictors for GR-mediated gene repression
2023 European Journal of Endocrinology

Quagliarini F, Makris K, Friano ME, Uhlenhaut NH

EJE Prize 2023: genes on steroids-genomic control of hepatic metabolism by the glucocorticoid receptor
2021 Cell Reports

Greulich F, Wierer M, Mechtidou A, Gonzalez-Garcia O, Uhlenhaut NH

The glucocorticoid receptor recruits the COMPASS complex to regulate inflammatory transcription at macrophage enhancers
2020 Nucleic Acids Research

Escoter-Torres L, Greulich F, Quagliarini F, Wierer M, Uhlenhaut NH

Anti-inflammatory functions of the glucocorticoid receptor require DNA binding
2019 Molecular Cell

Quagliarini F, Mir AA, Balazs K, Wierer M, Dyar KA, Jouffe C, Makris K, Hawe J, Heinig M, Filipp FV, Barish GD, Uhlenhaut NH

Cistromic Reprogramming of the Diurnal Glucocorticoid Hormone Response by High-Fat Diet
2019 Nature Communications

Hemmer MC, Wierer M, Schachtrup K, Downes M, Hübner N, Evans RM, Uhlenhaut NH

E47 modulates hepatic glucocorticoid action

Contact

Dr. Sybille Regn

Scientific Coordination

Judith Brehme

HELENA Graduate School Office, Scientific Talent and Career Development